Health Canada’s privatized medical marijuana program is risky for speculators, say national stock regulators. Canadian Securities Administrators cautioned buyers to use “significant due diligence” when purchasing shares in marijuana farms. The alert followed cautionary notes from insurers and physicians: “I worry”.